Moshe Manor

2017

In 2017, Moshe Manor earned a total compensation of $937.7K as President and Chief Executive Officer at Protalix BioTherapeutics, a 37% increase compared to previous year.

Compensation breakdown

Bonus$374,000
Option Awards$103,354
Salary$355,290
Other$105,056
Total$937,700

Manor received $374K in bonus, accounting for 40% of the total pay in 2017.

Manor also received $103.4K in option awards, $355.3K in salary and $105.1K in other compensation.

Rankings

In 2017, Moshe Manor's compensation ranked 9,266th out of 14,666 executives tracked by ExecPay. In other words, Manor earned more than 36.8% of executives.

ClassificationRankingPercentile
All
9,266
out of 14,666
37th
Division
Manufacturing
3,557
out of 5,770
38th
Major group
Chemicals And Allied Products
1,221
out of 2,074
41st
Industry group
Drugs
981
out of 1,730
43rd
Industry
Biological Products, Except Diagnostic Substances
175
out of 316
45th
Source: SEC filing on March 6, 2018.

Manor's colleagues

We found four more compensation records of executives who worked with Moshe Manor at Protalix BioTherapeutics in 2017.

2017

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2017

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2017

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

2017

Tzvi Palash

Protalix BioTherapeutics

Chief Operating Officer

News

You may also like